Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
We have performed mRNA in situ hybridization studies and northern blot analysis in the mouse and human, respectively, to determine the normal gene expression patterns of FMR-1. Expression in the adult mouse was localized to several regions of the brain and the tubules of the testes, which are two of the major organs affected in fragile X syndrome. Universal and very strong expression was observed in early mouse embryos, with differentially decreasing expression during subsequent stages of embryonic development. The early embryonic onset and tissue specificity of FMR-1 gene expression is consistent with involvement in the fragile X phenotype, and also suggests additional organ systems in which clinical manifestations of reduced FMR-1 gene expression may occur.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP is an RNA binding protein (Siomi et al., 1993) that is mainly expressed in the central nervous system (CNS) and gonads, and to lesser extent in other tissues (Hinds et al., 1993).”
From Astrocytes in fragile X syndrome (2024) · cites this paper as Hinds et al., 1993
In the citing paper
“Interestingly, the time point of the aberrant functional and structural connectivity coincides with the expression profile of the knockout genes, suggesting that the timing in which ASD risk-genes are functionally active is critical for the development of aberrant connectivity patterns and possibly behavioral symptoms later in life.”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Hinds et al. 1993
In the citing paper
“FMR1 plays a pivotal role in early embryotic neurodevelopment (Hinds et al. 1993) whereas the physiological expression of CNTNAP2 begins at around E14 but peaks during adulthood (P56) (Penagarikano et al. 2011).”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Hinds et al. 1993
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Self-citationFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Self-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Self-citationFragile X Genotype Characterized by an Unstable Region of DNA
Yu, S., Pritchard, M., Kremer, E., Lynch, M., Nancarrow, J., Baker, E., Holman, K., Mulley, J. C., Warren, S. T., Schlessinger, D., et al. (1991) · Science · doi:10.1126/science.252.5009.1179 · Cited by 794
Self-citationLubs, H. A. (1969) · PubMed · Cited by 662
A point mutation in the FMR-1 gene associated with fragile X mental retardation
De Boulle, K., Verkerk, A. J. M. H., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., Van Den Bos, F., de Graaff, E., Oostra, B. A., & Willems, P. J. (1993) · Nature Genetics · doi:10.1038/ng0193-31 · Cited by 624
Gene‐induced embryological modifications of primordial germ cells in the mouse
Mintz, B., & Russell, E. S. (1957) · Journal of Experimental Zoology · doi:10.1002/jez.1401340202 · Cited by 541
Cited by
Items 301–394 of 394
Neurotransmitter Signaling Before the Birth of Neurons
LoTurco, J. J., & Kriegstein, A. R. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0014 · Cited by 6
Analysis of FMRP, the protein deficient in fragile X syndrome
Small, K. M., & Warren, S. T. (1995) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1410010404 · Cited by 5
Self-citationFMR1 Disorders: Basics of Biology and Therapeutics in Development
Gillett, D. A., Tigro, H., Wang, Y., & Suo, Z. (2024) · Cells · doi:10.3390/cells13242100 · Cited by 6
“During early fetal development, FMRP is highly expressed throughout the body, but as the fetus matures, FMRP expression decreases to almost negligible levels except in the brain and the reproductive system [25].”
Geng, J., Wang, X., Pan, J., Khan, D., Pimcharoen, S., Zhang, Y., Mosammaparast, N., Hirose, S., Petrucelli, L., Brandman, O., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq3551 · Cited by 8
Fragile X Syndrome Pre-Clinical Research: Comparing Mouse- and Human-Based Models
Telias, M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9080-1_13 · Cited by 6
Borodyanskaya, M., Coffey, S. M., Ono, M. Y., & Hagerman, R. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511770708.002 · Cited by 7
Protein Synthesis at Synaptic Sites on Dendrites
Steward, O. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_4 · Cited by 7
Pathophysiology of Cortical Synapses and Circuits
Schwartzkroin, P. A. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0020 · Cited by 4
Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Monaghan, D. T., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107355 · Cited by 4
“FMRP is highly expressed in the brain (Hinds et al., 1993) and regulates protein expression and function at both the mRNA and protein levels (Li et al., 2001; Deng et al., 2013; Ferron et al., 2014; Brown et al., 2010; Laggerbauer et al., 2001).”
Thomas, S., Fayet, O., Truffault, F., Fadel, É., Provost, B., Hamza, A., Berrih‐Aknin, S., Bonnefont, J., & Panse, R. L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02311-y · Cited by 3
“The fact that FMR1 is well expressed in the thymus [7] and that its expression is influenced by environmental factors strongly suggest that it could play a critical role in the thymus and the immune system.”
BackgroundNelson, D. L., Santoro, M. R., & Warren, S. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00002-0 · Cited by 3
Self-citationA family with two cases of melanocytic tumors and fragile X syndrome
Lesage, C., Coupier, I., & Guillot, B. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000400 · Cited by 3
Structure and Alternative Splicing of the Antisense FMR1 (ASFMR1) Gene
Zafarullah, M., Li, J., Tseng, E., & Tassone, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03176-9 · Cited by 3
“The expression profile of the FMR1 gene shows its relatively high abundance in human tissues such as the brain, kidney, ovary, testes, and thyroid to barely detectable levels in skeletal muscle [15, 28].”
BackgroundFragile X allelemorphism among the mentally retarded and in affected families
Charles, A. (2009) · Scientific Research and Essays · doi:10.5897/sre.9000511 · Cited by 3
Fragile X-Linked Mental Retardation
Gantois, I., Kooy, R. F., & Oostra, B. A. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200300051 · Cited by 3
Kraus, J. E., & McNamara, J. O. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0019 · Cited by 3
Decreased FMR1 mRNA levels found in men with substance use disorders
Krasteva, M. E., Koycheva, Y., Racheva, R., Taseva, T., Raycheva, T., Simeonova, S., & Andreev, B. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05270 · Cited by 2
“The encoded RNA-binding protein (FMRP) has a multi-domain structure and though expressed ubiquitously, is most abundant in neurons and testis [8].”
BackgroundFragile X—A Family of Disorders: Changing Phenotype and Molecular Genetics
Spector, E. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1688-4_19 · Cited by 4
Crawford, D. C., & Howard‐Peebles, P. N. (2005) · Humana Press eBooks · doi:10.1385/1-59259-833-1:495 · Cited by 2
Prevalence of fragile X syndrome among patients with mental retardation in the west of Iran
Peyman, H., Haghani, K., Noori-Zadeh, A., & Bakhtiyari, S. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1508-0 · Cited by 2
Fragile X mental retardation protein interacts with TDG
Chen, Y., Bardoni, B., Yu, M., Zhu, N., Wu, G., Mandel, J., & Shen, Y. (2000) · Chinese Science Bulletin · doi:10.1007/bf02887096 · Cited by 2
Response to: X‐linked miR‐506 family miRNAs promote FMRP expression in mouse spermatogonia
Ramaiah, M., Tan, K., Plank, T. M., Song, H., Chousal, J. N., Jones, S. H., Shum, E. Y., Sheridan, S. D., Peterson, K. J., Gromoll, J., et al. (2019) · EMBO Reports · doi:10.15252/embr.201949354 · Cited by 2
Translational Control of Synaptic Plasticity and Memory
Khoutorsky, A., Gkogkas, C. G., & Sonenberg, N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3991-2_14 · Cited by 1
Path to understanding the pathophysiology of Fragile X syndrome
Mullé, J. G., Peñagarikano, O., & Warren, S. T. (2007) · Future Neurology · doi:10.2217/14796708.2.5.567 · Cited by 1
Self-citationСтаниславаовна, П. Д., Анатольевна, Т. С., Ulas, E., & Gorbachevskaya, N. L. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01371-2 · Cited by 1
“Postnatally, FMR1 mRNA is synthesized at the highest level in the brain, gonads, esophageal epithelium, thymus, eyes, and spleen [Hinds et al., 1993].”
BackgroundInstability of Tandem Repetitive DNA in “Natural” and Transgenic Organisms
Hankeln, T., Winterpacht, A., & Schmidt, E. (1996) · Springer eBooks · doi:10.1007/978-3-642-61460-6_19 · Cited by 2
Gene Control of Cortical Excitability
Noebels, J. L. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0015 · Cited by 1
Cortical Synaptic Transmission: An Overview
Stevens, C. F. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0002 · Cited by 1
Signal Transduction and Protein Phosphorylation
Schulman, H. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0004 · Cited by 1
Synaptic Actions of Amino Acid Neurotransmitters
Thompson, S. M., Madison, D. V., & Módy, I. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0006 · Cited by 1
Bush, P. C., & B, T. J. S. A. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0012 · Cited by 1
Structure and Function of Ligand-Gated Channels
Dingledine, R. J., & Bennett, J. A. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0005 · Cited by 1
Huot, M. (2005) · Corpus Université Laval (Université Laval) · Cited by 1
Huguenard, J. R., McCormick, D. A., & Coulter, D. A. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0011 · Cited by 2
Visual Spatial Learning and Memory in Fragile X Syndrome and fmr1 Knockout Mice
MacLeod, L. S. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-6693
“In both typically developing humans and wild-type mice, high levels of FMR1/fmr1 mRNAs are expressed in the hippocampus (Abitbol et al., 1993; Hinds et al., 1993), suggesting that this brain area is reliant on and therefore sensitive to changes in FMRP expression as occur in FXS. Impairments have…”
BackgroundInfluentialChapter 2 The Biology of Trinucleotide Repeat Disorders
Reddy, P. H., & Tagle, D. A. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60022-x · Cited by 2
Differentiation of neural stem cells in fragile X syndrome
Tervonen, T. A. (2008) · Helda - University of Helsinki Institutional Repository
Role of mGluR5 and FMRP in mouse primary somatosensory cortex
Wijetunge, L. S. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Molekulare Grundlagen neurologischer Trinukleotidblockexpansionssyndrome
Epplen, J. T., & Haupt, A. (2000) · Springer eBooks · doi:10.1007/978-3-642-57043-8_18
DNA Structures of Biological Relevance, Studies of Unusual Sequences
Wang, Y. (2000) · Wiley eBooks · doi:10.1002/9780470027318.a1409
Molecular Genetics and Prenatal Diagnosis
Phillips, J. A. (2009) · Wiley eBooks · doi:10.1002/9781444314342.ch11
Chapter 5.3 Trinucleotide repeat disorders
Sandberg, G., Lindblad‐Toh, K., Oostra, B. A., Schalling, M., Crusio, W. E., Gerlai, R. T., & Huston, J. P. (1999) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(99)80060-1
Variabilidade do domínio KH-2 da proteína do retardo mental do X frágil (FMRP)
Velloso, F. J. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2013.tde-21032014-090729
Relations Entre Génétique et Clinique du Développement
Lenoir, P., Malvy, J., & Bodier-Rethore, C. (2007) · Elsevier eBooks · doi:10.1016/b978-2-294-07171-3.50003-7
Análise da expressão do gene FMR1 no ovário
Fontes, L. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2011.tde-25042012-102756
Expressão de isoformas da proteína do retardo mental do X frágil (FMRP) e sua regulação
Velloso, F. J. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2008.tde-19032009-144613 · Cited by 3
Implicancias del gen FMR1 en la función ovárica
Ferder, I. C. (2014) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
The Molecular Biology of FXTAS
Tassone, F., & Hagerman, P. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1_6
Macroorchidisme et spermatogenèse dans le syndrome de l’X fragile
Pages, A., Gentil‐Perret, A., Lévy, R., Armand, C., & Tostain, J.-B. (2001) · Andrologie · doi:10.1007/bf03034635
Corrêa, J. D. C. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2014.tde-01092014-085006
History Tends to Repeat: FMR-1 Silencing in Fragile X Syndrome
Haas, J. G. (2007) · Eukaryon
Alegría, H. S. A., Lucero Rengifo, R., Serrano, H., Rueda, J. R., Aranda, E., & Gaviria, D. (2012) · Revista Médica de Risaralda (Technological University of Pereira) · doi:10.22517/25395203.8135
Molecular Characterisation and Assessment of Clinical Significance of Small Fragile X Alleles
Khaniani, M. S., & Derakhshan, S. M. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.5681/jarcm.2013.001
“The expression pattern of FMR1 at the mRNA and protein level is almost identical in various tissues of humans and mice.(57,61,62)”
BackgroundFragile X Syndrome: Steps towards Therapy
Pop, A. (2013) · RePub (Erasmus University Rotterdam)
Lucero Rengifo, R., Alegría, H. S. A., Rueda, J. R., García, D., & Aranda, E. (2012) · Revista Médica de Risaralda · doi:10.22517/25395203.8155
FRAGILE X SYNDROME IN NORTHERN FINLAND
Väisänen, M. (1999)
Multipotent neural stem/progenitor cells as a model of genetic neuronal diseases
Kärkkäinen, V. (2012) · UEF eRepo (University of Eastern Finland)
Pruksanusak, N., & Limprasert, P. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)
Clinical Strategies for Neuronal Protection
Albers, G. W. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0022
Kriegstein, A. R. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0013 · Cited by 1
Glutamate Receptors and Neuronal Death: A Beginning
Choi, D. W. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0018
Pathophysiology of Cortical Areas from Human Epileptics
Masukawa, L. M. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0021
Cortical Epileptogenesis in the Developing Human Brain
Kellaway, P. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.003.0017
Kurvinen, E., Puusepp, H., Rein, R., Žordania, R., & Jakovlev, Ü. (2008) · Ajakirjad. Journals by UT · doi:10.15157/ea.v0i0.10311
The Molecular Biology of Premutation Expanded Alleles
Tassone, F., Sellier, C., Charlet‐Berguerand, N., & Todd, P. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-33898-9_6 · Cited by 1
Virus-mediated Delivery of the Fmr1 Gene as a Tool for the Treatment of Fragile X Syndrome
Moghaddam, S. G. (2016) · TSpace (University of Toronto)
Casten, K. S., Gray, A. C., & Burwell, R. D. (2011)
Deficiency of Myelin Proteins during Brain Development in Fragile X Mice
Jiang, D. L. (2015) · TSpace (University of Toronto) · Cited by 1
Molecular mechanisms involved in altered differentiation of neural progenitors in Fragile X Syndrome
Achuta, V. S. (2018) · Helda - University of Helsinki Institutional Repository
Profilin isoforms in the hippocampus in health and disease
Zessin, S. (2014) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-201501221125-0
Molecular Correlates of Fragile X Syndrome and FXTAS
Tassone, F., & Hagerman, P. J. (2007) · Springer eBooks · doi:10.1007/3-540-33336-3_2
“4-kb transcript is observed by Northern blot analysis in brain, placenta, testis, lung, and kidney (Hinds et al. 1993).”
BackgroundRibeiro, M. D. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2018.tde-09052018-085516 · Cited by 1
Post-transcriptional Regulation of Myelin Basic Protein Expression
Giampetruzzi, A. (2014) · OpenCommons at University of Connecticut (University of Connecticut)
(1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.002.0004
(1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.002.0003
(1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.002.0007
(1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195083309.002.0005
Yotova, A. Y. (2024) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.85791 · Cited by 2
Astrocytic contribution to auditory hypersensitivity in a mouse model of fragile X syndromePreprint
Bergdolt, L., Anding, A., Alshaqi, O., Arbabi, Z., Douchey, M., Eldridge, E., Hoffman, K., Reid, A., Sapkota, K., Padmashri, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.14.638346
“FMRP is highly expressed in the brain (Hinds et al., 1993) and regulates protein expression and function at both the mRNA and protein levels (Brown et al., 2010; Deng et al., 2013; Ferron et al., 2014; Laggerbauer et al., 2001; Li et al., 2001).”
Dionne, O., Gaudreau, G.-L., Bergis, C., Avino, M., Sabatié, S., Corbin, F., & Laurent, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.31.673358
FMRP dependent synaptic delivery of messenger RNA
Kao, D.-I. (2011) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Kurosaki, T., Sakano, H., Pröschel, C., Wheeler, J., Hewko, A., & Maquat, L. E. (2021) · Figshare · doi:10.6084/m9.figshare.17030664
Kurosaki, T., Sakano, H., Pröschel, C., Wheeler, J., Hewko, A., & Maquat, L. E. (2021) · Figshare · doi:10.6084/m9.figshare.17030667
Kurosaki, T., Sakano, H., Pröschel, C., Wheeler, J., Hewko, A., & Maquat, L. E. (2021) · Figshare · doi:10.6084/m9.figshare.17030673
Kurosaki, T., Sakano, H., Pröschel, C., Wheeler, J., Hewko, A., & Maquat, L. E. (2021) · Figshare · doi:10.6084/m9.figshare.17030676
Studying Neuronal Connectivity in the Mouse Brain in Normal Condition and Fragile X Syndrome
Haberl, M. G. (2014) · theses.fr (ABES) · doi:10.70675/cbb47168z82fbz41a1z9174zd9e36b2b5a6d
Felgerolle, C. (2019) · theses.fr (ABES) · doi:10.70675/fbd5cf69zed5az4a57zbfdez48e26a937a72
Pathophysiological consequences of a Fragile X missense mutation
Garcia, M. P. (2020) · theses.fr (ABES) · doi:10.70675/b8e86263z5926z4a83zbaf6z0f61bf2d15f9
Rôle de la phosphodiestérase 2A dans la physiopathologie du syndrome de l’X fragile
Delhaye, S. (2021) · theses.fr (ABES) · doi:10.70675/e0fac395z63d4z46a4z944aza4037215ca98
Socio-communicative and nucleus accumbens core dysfunctions in fragile X syndrome
Giua, G. (2023) · theses.fr (ABES) · doi:10.70675/e45d048ez2538z4905zba74z1de16201406a
Paluszkiewicz, S. M. (2011) · DigitalGeorgetown (Georgetown University Library)
Molekulargenetische Grundlagen des fra(X)-Syndroms—Diagnostik und therapeutische Hilfen
Steinbach, P. J. (2000) · Springer eBooks · doi:10.1007/978-3-642-57043-8_17
Metadata
- Authors
- Hinds, H. L., Ashley, C. T., Sutcliffe, J. S., Nelson, D. L., Warren, S. T., Housman, D. E., & Schalling, M.
- Affiliations
- Massachusetts Institute of Technology (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature Genetics
- Published
- 1993-01-01
- Volume
- 3
- Issue
- 1
- Pages
- 36-43
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2014102314
- Cited by
- 396
- References
- 40
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 4 · 2021: 15 · 2020: 10 · 2019: 11 · 2018: 11 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 20 · 2013: 13 · 2012: 15
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-11-01)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hd029256-10)
- National Heart, Lung, and Blood Institute (5-P01-HL41484, P01HL041484)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 20521, 1 R01-HD29256)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Developmental Neuroscience › Williams Syndrome Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- FMR1 gene, fragile X syndrome, tissue-specific gene expression, embryonic development, brain expression, testicular tubules, mRNA in situ hybridization, Fmr1 knockout mice
- MeSH terms
- Adult, Animals, Base Sequence, Brain, DNA, Single-Stranded, Fetus, Fragile X Syndrome, Humans, Male, Molecular Sequence Data, Nerve Tissue Proteins, Organ Specificity, Testis, Blotting, Northern, Gene Expression, RNA-Binding Proteins, In Situ Hybridization, Mice, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.